Investing in drug-resistant tuberculosis household contact management and preventive treatment

Lancet Glob Health. 2022 Jul;10(7):e942-e943. doi: 10.1016/S2214-109X(22)00200-5. Epub 2022 May 18.

Authors

Hamidah Hussain¹, Amyn A Malik²

Affiliations

¹ Interactive Research and Development Global, 238884 Singapore. Electronic address: hamidah.hussain@ird.global.
² Interactive Research and Development Global, 238884 Singapore; Internal Medicine, Yale School of Medicine and Yale Institute for Global Health, Yale University, New Haven, CT, USA.

PMID: 35597250
DOI: 10.1016/S2214-109X(22)00200-5

No abstract available

Publication types

Comment

MeSH terms

Antitubercular Agents / therapeutic use
Humans
Tuberculosis, Multidrug-Resistant* / drug therapy
Tuberculosis, Multidrug-Resistant* / epidemiology
Tuberculosis, Multidrug-Resistant* / prevention & control

Substances

Antitubercular Agents